20213 ⎘
Medicinal preparations containing organic active ingredients; Ketones acyclic
S-BETA-HYDROXYBUTYRIC ACID COMPOSITIONS AND METHODS FOR DELIVERY OF KETONE BODIES
#2METHOD AND COMPOSITION FOR ENHANCING EXERCISE PERFORMANCE
#3MODIFIED RELEASE TOLCAPONE FORMULATIONS
#4NEOCARZILIN DERIVATIVES AS ANTIMETASTATIC AGENTS
#5NEURAL REPAIR COMPOSITION, METHOD OF PREPARATION, AND USE THEREOF
#6AGRIMOL B DERIVATIVES AND METHODS OF MAKING AND USE THEREOF
#7TRANSDERMAL DELIVERY FORMULATIONS
#8LIVER HEALTH SUPPLEMENT FOR COMPANION ANIMALS
#9PHARMACEUTICAL COMPOSITIONS FOR USE IN TREATING OBSTRUCTIVE SLEEP APNEA
#10ECO-SKIN: A Kombucha SCOBY-Derived Cellulose Matrix for Accelerated Healing and Antimicrobial Defense
#11Treatment of Neuroinflammation
#12FUSED AMINO PYRIMIDINE COMPOUNDS FOR TREATMENT OF PSYCHOSIS AND PSYCHOTIC DISORDERS
#13COMPOSITION AND USE THEREOF
#14ORODISPERSIBLE TABLET, IN PARTICULAR FOR USE AS A FOOD SUPPLEMENT
#15NANOSYSTEMS BASED ON NANOCOMPOSITES AND NATURAL EXTRACTS
#16COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS (TTFIELDS) AND METHYLGLYOXAL
#17SUNSCREEN COMPOSITION FOR LACTOBACILLUS AND S. EPIDERMIDIS PROTECTION ON SKIN
#18COMPOSITIONS AND METHODS FOR THE MODULATION OF PIEZO1 AND TRPV4
#19ANTI-INFLAMMATORY PHYTONUTRIENTS FOR USE IN THE TREATMENT OR PREVENTION OF SYNOVITIS
#20METHOD FOR PREVENTING AND/OR TREATING CANCER OR AUTOIMMUNE DISEASE WITH 3,4,2 Prime,3 Prime,4 Prime-PENTAHYDROXY-TRANS-CHALCONE
#21VCP INHIBITORS AND USES THEREOF FOR TREATMENT
#22COMBINATION OF A KETONE BODY OR KETOGENIC COMPOUND WITH AN ANALGESIC OR ANTIOXIDANT
#23MICROBIOTA IMPROVING AGENT
#24VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS
#25METHOD FOR TREATMENT OF PARKINSON'S DISEASE
#26COMPOSITIONS AND METHODS USING A NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) PRECURSOR AND AT LEAST ONE KETONE OR KETONE PRECURSOR
#27METHODS FOR INHIBITING PARASITIC GLUCOKINASE AND/OR HEXOKINASE
#28TRANSDERMAL DELIVERY FORMULATIONS
#29S-BETA-HYDROXYBUTYRIC ACID COMPOSITIONS AND METHODS FOR DELIVERY OF KETONE BODIES
#30DIALYSIS FLUID COMPRISING KETONE BODIES FOR THE TREATMENT OF CANCER
#31TRANSDERMAL DELIVERY FORMULATIONS
#32METHODS AND AGENTS FOR MODULATING THE IMMUNE RESPONSE
#33METHODS, COMPOSITIONS AND DEVICES FOR TREATING CANCER WITH ILLUDOFULVENES
#34COMPOSITIONS FOR ORAL CANCER OR AN OROPHARYNGEAL CANCER
#35CO-CRYSTAL COMPOSITION AND ITS PHARMACEUTICAL USE
#36METHODS FOR TREATING CANCERS
#37MIXTURE FOR TREATMENT OF RESPIRATORY ILLNESSES
#38METHODS AND COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS CLASS I MUTATIONS
#39Solid Solution Compositions and Use in Severe Pain
#40Compositions for blood storage and transfusions
#41USE OF EXOGENOUS KETONE ESTERS TO INDUCE WEIGHT LOSS IN MAMMALS
#42ANTI-INFLAMMATORY PHYTONUTRIENTS FOR USE IN THE TREATMENT OR PREVENTION OF SYNOVITIS
#43PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, AND PREPARATION METHOD AND USE THEREOF
#44Transdermal delivery formulations
#45COMPOSITIONS AND METHODS RELATED TO RHAMNUS PRINOIDES (GESHO) EXTRACT FOR THE INHIBITION OF POLYMICROBIAL BIOFILM FORMATION
#46Agmatine compositions for treatment of osteoarthritis
#47NANOSYSTEMS BASED ON NANOCOMPOSITES AND NATURAL EXTRACTS
#48TRANSDERMAL DELIVERY FORMULATIONS
#49COMPOSITIONS AND METHODS FOR KETO STACKING WITH BETA-HYDROXYBUTYRATE AND ACETOACETATE
#50BETA-HYDROXYBUTYRIC ACID COMPOSITIONS AND METHODS FOR DELIVERY OF KETONE BODIES
#51ACTIVE AGENT MODULATING THE ACTIVITY OF AN ION CHANNEL FOR USE IN HAIR GROWTH REGULATION
#52Antimicrobial Diapering Device
#53Transdermal delivery formulations
#54BETA-HYDROXYBUTYRIC ACID COMPOSITIONS AND METHODS FOR ORAL DELIVERY OF KETONE BODIES
#55COMPOSITIONS AND COMBINATIONS FOR SUBJECTS SUFFERING FROM ENDOMETRIOSIS
#56METHOD OF USING SUBSTRATES OF AKR1Bl/AKR1B10 AS ANTI-CANCER DRUGS
#57Method and Composition for Treating Ringworm on Biotic and Abiotic Surfaces
#58A NOVEL METHOD FOR CARRYING BIOACTIVE MOLECULES USING NANOCARRIERS
#59ALPHA LIPOIC ACID, EPIGALLOCATECHIN 3-GALLATE, AND CURCUMIN AS A MEDICAMENT FOR THE TREATMENT OF ARTHRITIS AND SARS-COV-2
#60COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR FLAVONOIDS AND USES THEREOF
#61NUTRITIONAL HEALTH SUPPLEMENTS
#62TRANSDERMAL DELIVERY FORMULATIONS
#63VIRAL TREATMENTS INVOLVING MANUKA HONEY AND COMPONENTS THEREOF
#64TREATMENT OF PAIN BY TARGETING NR4A1
#65PLANT BASED SUPPLEMENT COMPOSITIONS
#66DIMETHYLTRIPTAMINE-BASED NASAL SPRAY FOR THE PERSONALISED TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
#67COMPOSITION CONTAINING CURCUMIN COMPOUND, AND METHOD FOR PRODUCING SAME
#68FORMULATION, COMPOSITION OR FOODSTUFF ADDITIVES FOR THE MODIFICATION OF GLYCEMIC RESPONSE METHODS OF MANUFACTURING AND USING THE SAME
#69METHOD FOR TREATMENT OF PARKINSON'S DISEASE
#70CANCER TREATMENT METHOD AND MEDICINE
#71Composition for prevention or treatment of Porcine epidemic diarrhea virus infection comprising curcuminoid and licorice extracts or fraction thereof
#72Synthetic antibacterial compounds and uses thereof
#73TREATMENT OF MAJOR DEPRESSIVE DISORDER BY LOW DOSE INTERLEUKIN-2
#74METHODS OF TREATING LIPEDEMA INCLUDING AKR1C1 AS A THERAPEUTIC TARGET
#75SMALL MOLECULE INHIBITORS OF A PROTEIN COMPLEX
#76PHOSPHOLIPASE-A2 INHIBITORS FOR THE PREVENTION OF CANCER METASTASIS
#77COMPOSITIONS AND METHODS FOR TREATMENT OF A FIBROTIC DISEASE
#78CO-CRYSTAL COMPOSITION AND ITS PHARMACEUTICAL USE
#79Dihydrochalcone derivatives influencing inflammatory states
#80Curcumin Solubilisate
#81METHODS AND COMPOSITIONS FOR TREATING DYSBIOSIS OF ORAL MICROBIOME
#82COMPOSITIONS AND METHODS RELATED TO TETHERED KETHOXAL DERIVATIVES
#83ANTI-MICROBIAL METHODS AND MATERIALS
#84Transdermal delivery formulations
#85TRANSDERMAL DELIVERY FORMULATIONS
#86Solid solution compositions and use in severe pain
#87Solid solution compositions comprising cannabidiols
#88Methods, compositions and devices for treating cancer with illudofulvenes
#89ANTIVIRAL THERAPEUTIC DRUG COMBINATIONS
#90Treatment of cutaneous disorders
#91OZONOLYSIS FOR ACTIVATION OF COMPOUNDS AND DEGRADATION OF OZONE
#92Compositions for oral cancer or an oropharyngeal cancer
#93COMPOSITIONS AND METHODS USING A NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) PRECURSOR AND AT LEAST ONE KETONE OR KETONE PRECURSOR
#94GLYCOALKALOID COMBINATIONS AND VARIOUS USES THEREOF
#95Solid solution compositions and use in chronic inflammation
#96Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
#97COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS
#98Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
#99Compositions and methods related to (GESHO) extract for the inhibition of polymicrobial biofilm formation
#100Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide
#101COMPOSITIONS AND METHODS USING A NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) PRECURSOR AND AT LEAST ONE KETONE OR KETONE PRECURSOR
#102METHOD FOR TREATMENT OF PARKINSON'S DISEASE
#103Use of compositions comprising dihydroxyacetone for the protection of skin or hair against infrared irradiation
#104DRUG DELIVERY BY PORE-MODIFIED MESOPOROUS SILICA NANOPARTICLES
#105METHODS OF PROTECTING AN ORGAN USING TETRAHYDROCURCUMIN AND PHOSPHATIDYLCHOLINE
#106POLYMER FILMS WITH ANTIMICROBIAL AGENTS
#107COMBINATION THERAPY COMPRISING A POLYUNSATURATED KETONE AND A CORTICOSTEROID
#108Solid solution compositions and use in severe pain
#109FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF
#110Solid solution compositions and use in cardiovascular disease
#111Pharmaceutical combinations and methods for the treatment of diabetes and associated disorders
#112Pharmaceutical composition
#113Composition and uses thereof
#114Solid solution compositions and use in chronic inflammation
#115HISTONE DEACETYLASE INHIBITORS
#116Treatment of cutaneous disorders
#117Compositions Comprising Cancer Drug-Fatty Acid Conjugates
#118Treatment of vulvar pain
#119Methods for treating diseases
#120Buckwheat honey and bacitracin wound-healing dressing
#121METHODS OF TREATING LEUKODYSTROPHIES
#122Wound healing compositions and methods of use
#123TREATMENT FOR GLIOBLASTOMA
#124FATTY ACID CYSTEAMINE CONJUGATES AND THEIR USE AS ACTIVATORS OF AUTOPHAGY
#125Compositions Containing Enriched Natural Crocin and/or Crocetin, and Their Therapeutic or Nutraceutical Uses
#126PHARMACEUTICAL COMPOSITION
#127Absorption promoter and use for same
#128Compositions for the treatment of skin conditions
#129Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
#130A NATURAL COMPOSITION TO INHIBIT BETA-SECRETASE AND ENHANCE BIOAVAILABILITY COMPRISING OF TURMERIC AND SESAME SEED EXTRACT
#131Compositions for atopic skin
#132Myricanol Derivatives and Uses Thereof for Treatment of Neurodegenerative Diseases
#133COMBINATION THERAPY COMPRISING A POLYUNSATURATED KETONE AND A FOLIC ACID PARTNER
#134FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF
#135Dermatitis treatment
#136Transmucosal Delivery of Terpenes Via Edible Film
#137Preservation booster
#138Treatment of heart failure with preserved ejection fraction
#139Coatings and methods for infection-resistant medical devices
#140Method of using substrates of AKR1B1/AKR1B10 as anti-cancer drugs
#141Solid solution compositions and use in chronic inflammation
#142Solid solution compositions and use in severe pain
#143Solid solution compositions and use in cardiovascular disease
#144Combination therapy for proliferative diseases
#145Solid solution compositions and use in chronic inflammation
#146OLFR90 specificity and methods of detection
#147Crosslinker enhanced repair of connective tissues
#148Topical Treatment Compositions Comprising Benzoin and Olive Fruit Extract
#149Solid solution compositions and use in chronic inflammation
#150Solid solution compositions and use in chronic inflammation
#151Use of dihydroxyacetone in preparation of anti-cancer medicaments
#152Histone deacetylase inhibitors
#153Methods of quantifying N-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG
#154Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases
#155Compositions and methods for selectively inhibiting intestinal carboxylesterase 2 enzyme activity
#156COMPOSITION AND METHOD FOR INHIBITION OF NERVE TRANSMISSION
#157HOPS-BASED SUBSTANCE AND USE OF THE SUBSTANCE
#158HONEY FORTIFIED WITH DIHYDROXYACETONE AND METHODS OF MAKING SAME
#159Solid solution compositions and use in chronic inflammation
#160Solid solution compositions and use in chronic inflammation
#161Solid solution compositions and use in chronic inflammation
#162Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases
#163Active substances and cosmetic or dermatological preparations containing said active substances for the care of the skin of patients of diabetes mellitus
#164Development of curcumin and piperine loaded double-layered biopolymer based nano delivery systems by using electrospray / coating method
#165Wound Healing Composition Involving Mineral Ions and Methylglyoxal, and Methods of Use
#166FIBROTIC TISSUE STABILIZED BY CROSSLINKING FOR TREATMENT OF SNORING AND OBSTRUCTIVE SLEEP APNEA
#167COMPOSITIONS AND METHODS FOR ENHANCING THE METABOLIC ACTIVITY OR STABILITY OF CURCUMIN
#168Reduction in CPC taste aversion by reducing CPC activation of TRPA1, TPRV1, or both
#169CURCUMIN-BASED COMPOSITIONS & METHODS OF USE THEREOF
#170Process for preparation of bioavailable white curcumin—a unique blend of hydrogenated curcuminoids
#171AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES
#172Fatty acid cysteamine conjugates and their use as activators of autophagy
#173Photodynamic diagnosis, formulations usable as photosensitizers for this purpose, method for the production and use thereof
#174Skin cancer treatment
#175COMPOSITIONS AND METHODS TO TREAT NEUROPATHY AND RELATED CONDITIONS
#176Treatment for glioblastoma
#177Pharmaceutical compositions comprising hemp and turmeric to treat pain and inflammation
#178Methods of protecting an organ using tetrahydrocurcumin and phosphatidylcholine
#179Method for adjunctive treatment of cancer metastasis by using lycogen
#180Multitarget hedgehog pathway inhibitors and uses thereof
#181Pharmaceutical composition for preventing or treating cancer, containing proteasome inhibitor and loperamide as active ingredients
#182Solid solution compositions and use in chronic inflammation
#183Agent for inhibiting odor of pyrazine derivatives
#184Solid solution compositions and use in chronic inflammation
#185Dihydroorotic and acid dehydrogenase inhibitor
#186Reduction in CPC taste aversion by reducing CPC activation of TRPA1, TPRV1, or both
#187Activity Enhancing Curcumin Compositions and Methods of Use
#188Therapeutic agents for skin diseases and conditions
#189ANTI-INFLAMMATORY PHYTONUTRIENTS FOR USE IN THE TREATMENT OR PREVENTION OF SYNOVITIS
#190Methods of stabilizing the extracellular matrix and compositions therefor
#191Wound healing compositions comprising buckwheat honey and methylglyoxal and methods of use
#192Compositions containing enriched natural crocin and/or crocetin, and their therapeutic or nutraceutical uses
#193Solid solution compositions and use in chronic inflammation
#194Reactive oxygen species (ROS)-responsive compositions and methods thereof
#195AGENT OR METHOD FOR TREATEMENT AND/OR PREVENTION OF ACCELERATED ENERGY EXPENDITURE AND/OR DIMINISHED ENERGY EXPENDITURE FUNCTIONALITY
#196OPHTHALMIC COMPOSITION
#197Methods and compositions for enhancing skin pigmentation
#198Curcumin solubilisate
#199COMPOSITIONS COMPRISING PLANT PROTEINS AND METHODS FOR PREVENTION OF METABOLIC AND CARDIOVASCULAR PATHOLOGIES IN PATIENT WITH CARDIOMETABOLIC RISK, INCLUDING HYPERGLYCEMIA
#200PROTEIN-GRAPHENE NANOCOMPOSITE DRUG CARRIER
#201KIT OF OPHTHALMIC COMPOSITION
#202Methods and compositions for preventing and treating electrophile-mediated toxicities
#203Compositions and methods including leelamine and arachidonyl trifluoromethyl ketone relating to treatment of cancer
#204METHOD FOR TREATMENT OF PARKINSON'S DISEASE
#205COMBINATION OF GERANYLGERANYLACETONE AND IBUDILAST AND METHODS OF USING SAME
#206Honey and silver nitrate composition, composition dressing and methods of making same
#207Curcumin solubilisate
#208Dermatitis treatment
#209Pharmaceutical composition on the basis of phyto-nutrients with increased bioavailability, having anti-tumor activity, and method for producing said composition (alternatives)
#210TREATING OSTEOPENIA AND RELATED DISORDERS WITH GERANYLGERANYL ACETONE AND DERIVATIVES THEREOF
#211Use of polyunsaturated ketones for the treatment of psoriasis
#212Methods for treating or preventing brain infections
#213MECHANISM, DIAGNOSTIC, AND TREATMENTS FOR COMPLICATIONS OF RENAL FAILURE
#214Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases
#215Molecule mixture comprising an amphipathic molecule type A, which has a positive total charge in the hydrophilic range, and an amphipathic molecule type B and A polyphenol C, method for producing said molecule mixture and use thereof
#216OPHTHALMIC COMPOSITION
#217Compositions comprising exemestane and novel methods of use
#218Therapeutic curcumin derivatives
#219OPHTHALMIC COMPOSITION COMPRISING GERANYLGERANYLACETONE
#220SYSTEMS, METHODS, AND COMPOSITIONS FOR CROSS-LINKING
#221UTILIZATION OF THE FUNCTION OF RARE SUGAR AS PROMOTER FOR THE MIGRATION OF GLUCOKINASE FROM NUCLEUS TO CYTOPLASM
#222Product and method for improving bioavailability of therapeutic compounds
#223Treating osteopenia and related disorders with geranylgeranyl acetone and derivatives thereof
#224Geranylgeranyl acetone and derivatives thereof for intranasal administration
#225Therapeutic uses of geranylgeranyl acetone and derivatives thereof
#226Compositions and methods for the treatment of glomerulonephritis
#227Anticonvulsant activity of turmeric oil and bisabolene sesquiterpenoids
#228MUCOSALLY-APPLIED AGENT FOR PREVENTION, AMELIORATION OR TREATMENT OF RETINAL DISEASE
#229Selective metabolic approach to increasing oral bioavailability of phenylephrine and other phenolic bioactivities
#230Poly (3-Hydroxybutyrate/3-Hydroxyvalerate) of Lowered Crystallinity for Use in Animal Feed
#231USAGE OF SODIUM HOUTTUYFONATE ON INHIBITING IDIOPATHIC PULMONARY FIBROSIS AND BLEOMYCIN INDUCED PULMONARY FIBROSIS
#232GERANYLGERANYLACETONE FORMULATIONS AND RETINAL DELIVERY THEREOF
#233Geranylgeranylacetone formulations and retinal and systemic delivery thereof
#234GERANYLGERANYLACETONE FORMULATIONS
#235Solid solution compositions and use in chronic inflammation
#236Solid Solution Compositions and Use in Severe Pain
#237Crosslinker enhanced repair of connective tissues
#238Antimicrobial Compositions
#239Agent for the prevention, improvement or treatment of retinal disease
#240Solid Solution Compositions and Use in Cardiovascular Disease
#241LOCAL ANAESTHETIC
#242Methods for treating prostate cancer
#243CHALCONE DERIVATIVES AS NRF2 ACTIVATORS
#244CANCER WITH METABOLIC THERAPY AND HYPERBARIC OXYGEN
#245KIT OF OPHTHALMIC COMPOSITION
#246KIT OF OPHTHALMIC COMPOSITION
#247Use of polyunsaturated ketones for the treatment of psoriasis
#248AGENT FOR THE PREVENTION, IMPROVEMENT OR TREATMENT OF RETINAL DISEASE
#249OPHTHALMIC COMPOSITION COMPRISING GERANYLGERANYLACETONE
#250Chemosensory Receptor Ligand-Based Therapies
#251TRANSDERMAL FORMULATIONS OF GERANYLGERANYLACETONE
#252Rheumatoid arthritis treatment
#253GERANYLGERANYLACETONE FORMULATIONS AND RETINAL DELIVERY THEREOF
#254Pharmaceutical compositions of curcumin
#255Method for Stimulating the Reproductive Capacity in a Bull, and Composition for Stimulating the Reproductive Capacity in a Bull
#256Process for preparing curcumin encapsulated chitosan alginate sponge useful for wound healing
#257Methods and compositions for treating conditions mediated by oxidative stress or electrophilic environmental toxins
#258Inhibitors of influenza endonuclease activity and tools for their discovery
#259Formulation containing curcuminoids exhibiting enhanced bioavailability
#260INHIBITING STOMACH-ACID RELEASE, REDUCING INFLAMMATION AND PREVENTING AND TREATING CANCER: COMPOSITIONS AND METHODS OF USE
#261Methods and compositions for controlled delivery of phytochemical agents
#262Anticancer Compounds from Vernonia Guineensis
#263Methods and compositions for heavy metal detoxification
#264Equine nutritional supplement
#265Family of PFKFB3 inhibitors with anti-neoplastic activities
#266METHODS FOR TREATING NEURODEGENERATIVE DISEASES
#267Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, and preparation method and use thereof
#268COMPOSITIONS AND APPLICATIONS OF CAROTENOIDS OF IMPROVED ABSORPTION AND BIOAVAILABILITY
#269DNA methylation inhibitors
#270Glomerulonephritis Treatment
#271Use of panduratin derivative or extract
#272Pharmaceutical composition and use of the pharmaceutical composition for the treatment, prophylaxis or prevention of neoplastic diseases in humans and animals
#273COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING RADIATION INJURY
#274Lycogen extract, composition thereof and method for the treatment using the same
#275APOE4 AND APOJ BIOMARKER-BASED PREVENTION AND TREATMENT OF DEMENTIA
#276DISPERSION COMPOSITION AND METHOD FOR MANUFACTURING DISPERSION COMPOSITION
#277Use of gingerols for cancer patients suffering from nausea and emesis induced by chemotherapy
#278Compounds and methods for treatment of stroke
#279Antimicrobial compositions
#280Composition and method for inhibition of nerve transmission
#281ANT4 INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF
#282Compositions and methods for enhancing immune response
#283Compositions comprising terpene compounds for treating negative sensory phenomena
#284In vivo assessment of toxicity and pharmacokinetics of methylglyoxal
#285Methods for treating or preventing brain infections
#286Modulation of the Phospholipase A2 Pathway as a Therapeutic
#287METHODS OF THERMOGRAPH-GUIDED MEDICAL TREATMENT
#288Compositions and methods for the treatment of glomerulonephritis
#289Use of a Monoterpene to Increase Tissue Repair
#290Method of inhibiting the growth of
#291COMPOSITIONS CONTAINING CHALCONES AND USE THEREOF
#292Fluorene compound and pharmaceutical use thereof
#293Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
#294Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
#295Use of polyunsaturated ketones for the treatment of psoriasis
#296VAGINAL ODORANTS
#297UTILIZATION OF THE FUNCTION OF RARE SUGAR AS PROMOTER FOR THE MIGRATION OF GLUCOKINASE FROM NUCLEUS TO CYTOPLASM
#298USE OF AT LEAST ONE CYTOSOLIC PHOSPHOLIPASE A2 INHIBITOR AS A MEDICINE FOR SYMPTOMATIC TREATMENT OF MUCOVISCIDOSIS
#299HERBAL MEDICAMENTS FOR THE TREATMENT OF NEUROCEREBROVASCULAR DISORDERS
#300USE OF HEAT SHOCK TO TREAT OCULAR DISEASE